CBD at higher concentration (30 μM) induced cell death in human T24 bladder cancer cells through activating TRPV2 [142], and CBD decreased glioma stem-like cell viability with an IC50 of nearly 20 μM in a TRPV2-dependent manner [79]. The gene discussed is TRPV2; the disease is urinary bladder cancer.